Pulmonary Disease, Chronic Obstructive: all 4,252 studies

Page 32 of 43. Open to participants first (707), then studies with results posted, then the rest; newest registration first within each.

• Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT02194205Phase 3
• Impact of Early Respiratory Rehabilitation in the Exacerbations of Re-admitted COPD PatientsCompletedNCT02190461Not applicable
• Efficacy and Safety of Glycopyrrolate Bromide of COPD PatientsCompletedNCT02189577Phase 2
• Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in GreeceCompletedNCT02187926
• Effects of Inspiratory Muscle Training on Breathing Pattern in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02186340Not applicable
• Combivent® HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease)TerminatedNCT02182869Phase 2
• Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPDCompletedNCT02182856Phase 4
• A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02182674Phase 2
• Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02182635Phase 3
• Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02182583Phase 3
• Acute Effect of Aclidinium on Hyperinflation and Ventilation Inhomogeneity in Severe COPD PatientsCompletedNCT02181023Phase 4
• Identifying REsponders and Exploring Mechanisms of ACTION of the Endobronchial Coil Treatment for EmphysemaCompletedNCT02179125Not applicable
• Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary DiseaseCompletedNCT02177344Phase 3
• Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02177318
• Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary DiseaseCompletedNCT02177253Phase 3
• Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02176564
• Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT02176200Phase 3
• Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary DiseaseTerminatedNCT02176187Phase 3
• Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02175342Phase 2
• Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed ConditionCompletedNCT02173795Phase 3
• Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02173782Phase 3
• Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD)CompletedNCT02173691Phase 3
• Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172807Phase 3
• Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172794Phase 3
• A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat InhalerCompletedNCT02172560
• Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.CompletedNCT02172547
• Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven HyperinflationCompletedNCT02172521
• Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary RehabilitationTerminatedNCT02172508Phase 4
• Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily PracticeCompletedNCT02172495
• Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172482
• Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172469Phase 3
• Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172456Phase 3
• Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary DiseaseCompletedNCT02172443Phase 3
• Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172430Phase 3
• HandiHaler® vs. Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172404Phase 3
• Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172391Phase 3
• 12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea ScalesCompletedNCT02172378Phase 3
• Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT02172352Phase 2
• Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD)CompletedNCT02172326Phase 3
• Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172300Phase 3
• Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172287Phase 3
• Quadricipital Electrical Stimulation in COPD Patients RehabilitationCompletedNCT02171377Not applicable
• Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract InfectionsStatus unknownNCT02171338Phase 4
• Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.CompletedNCT02165046Phase 1
• Is COPD a Risk Factor for Cardiovascular Disease?CompletedNCT02162095
• Safety, Tolerability and Preliminary Efficacy of Adipose Derive Stem Cells for Patients With COPDTerminatedNCT02161744Phase 1
• Physical Activity Versus Pulmonary Rehabilitation in COPDCompletedNCT02161393Not applicable
• Impact of "Telecoaching Program" on Physical Activity in Patients With COPDCompletedNCT02158065Not applicable
• Fat Metabolism in OSA and COPDCompletedNCT02157844
• Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric TrainingCompletedNCT02156245Not applicable
• Study of Airflow in the Lungs Using Helium MRICompletedNCT02154568Not applicable
• Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and SleepCompletedNCT02150590Phase 4
• Dietary Nitrate in COPDCompletedNCT02148289Not applicable
• Evaluation of Depression In Chronic Obstructive Pulmonary DiseaseStatus unknownNCT02147912Not applicable
• Personalized Variable Versus Fixed Dose Glucocorticoid Therapy in AECOPDCompletedNCT02147015Not applicable
• Music Therapy in the Treatment of Chronic Obstructive Pulmonary DiseaseCompletedNCT02146235Not applicable
• Cognitive Status in Chronic Obstructive Pulmonary Disease's PatientsStatus unknownNCT02143700
• Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise PerformanceCompletedNCT02143609Phase 4
• Modifying Exercise for the COPD PatientCompletedNCT02143206
• A Comparison Study of Two Respiratory Physical Therapy Methods and Standard Medical Treatment for Treating COPD Patients During Acute ExacerbationStatus unknownNCT02140892Not applicable
• A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPDCompletedNCT02140346Phase 1
• Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an ExacerbationCompletedNCT02136875Phase 4
• Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce ReadmissionsCompletedNCT02135744Not applicable
• Azithromycin for Acute Exacerbations Requiring HospitalizationTerminatedNCT02135354Phase 3
• Single Ascending Dose Study of TRN-157 in Healthy SubjectsCompletedNCT02133339Phase 1
• Efficacy of Inhalation Technique Training.CompletedNCT02131454Not applicable
• Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02128529
• Evaluating the Effect of Oxygentherapy on Concentration at Chronic Lung PatientsCompletedNCT02125916Not applicable
• Exercise and Neutrophil Function in COPDCompletedNCT02124343Not applicable
• Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPDCompletedNCT02123199
• Vitamin D Supplementation in Patients With COPDCompletedNCT02122627Not applicable
• Home-monitoring and Adherence of Patients With COPD to Long-term RehabilitationCompletedNCT02122614Not applicable
• Phenotypes of COPD in Central and Eastern EuropeCompletedNCT02119494
• Validation of Medication Non-adherence Model (UK)CompletedNCT02115412
• Is it Necessary to Set External PEEP in AECOPD PatientsCompletedNCT02114567Not applicable
• Downhill Walking Training in COPDStatus unknownNCT02113748Not applicable
• Systematic Follow-up of Patients Surviving an Episode of Acute Hypercapnic Respiratory Failure in the ICUCompletedNCT02111876
• Efficacy and Safety Study of Two Dose Levels of AZD2115 in Subjects With Moderate to Severe COPDCompletedNCT02109406Phase 2
• Effect of Oxygen Supplementation During Exercise in Chronic Obstructive Pulmonary Disease PatientsCompletedNCT02108925Not applicable
• The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD)WithdrawnNCT02107222Not applicable
• Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady StateCompletedNCT02103374Phase 4
• Nutritional Supplementation in Adults With Chronic Respiratory DiseaseCompletedNCT02102009Not applicable
• The Effect of NIV on QoL and Exercise Capacity in a COPD Exercise Rehabilitation ProgramTerminatedNCT02100709Not applicable
• A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02100332
• Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease PatientsStatus unknownNCT02093195Phase 2
• Endothelial Dysfunction and Chronic Obstructive Pulmonary DiseaseCompletedNCT02092675
• Physical Activity and Self-Efficacy After Pulmonary RehabilitationStatus unknownNCT02086383
• ECCO2R as an Adjunct to NIV in AECOPDCompletedNCT02086084Not applicable
• Early Telemedicine Training in Patients With COPDCompletedNCT02085187Not applicable
• Nitrate Supplementation in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02084758Not applicable
• Efficacy and Physiology of Nasal High Flow TherapyCompletedNCT02083120Not applicable
• Balance Training for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02080442
• Single Portable Pulse-dose-conserving Device vs. Combined Use of Stationary and Portable.CompletedNCT02079753Phase 3
• Use of Respiratory Therapists (RTs) to Improve Outcomes and Quality of Life in Patients With COPDCompletedNCT02078622
• Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles ComparisonCompletedNCT02076269Phase 1
• Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal StudyCompletedNCT02076061
• Inspiratory Muscle Training During Pulmonary Rehabilitation in COPDCompletedNCT02074813Not applicable
• Efficacy of Simvastatin for the Treatment of COPDCompletedNCT02070133Phase 3
• Post Marketing Surveillance of Roflumilast in KoreaCompletedNCT02068456
• Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPDCompletedNCT02067780Phase 3

← Pulmonary Disease, Chronic Obstructive overview